Clinical Trial Update: SST0001 (Roneparstat) in Advanced Multiple Myeloma [Phase 1]

View source ↗

Summary

Phase 1 study of SST0001 (Roneparstat) in advanced multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Roneparstat (SST0001) (Roneparstat)

Snippet

Sponsor: Sigma Tau Research Switzerland SA | Conditions: Multiple Myeloma | Phase 1 | Status: COMPLETED